Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers

Journal of Neuroscience

Volumn 27, Issue 8, 2007, Pages 1964-1972

  Hope, Bruce T ^a   Nagarkar, Deepti ^a   Leonard, Sherry ^b   Wise, Roy A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Addiction; cAMP; Neuroadaptations; Nicotine; Nucleus accumbens; PKA

Indexed keywords

ADENYLATE CYCLASE; BRAIN PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ADAPTATION; ADDICTION; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOKING;

ADAPTATION, PHYSIOLOGICAL; ADENYLATE CYCLASE; ADOLESCENT; ADULT; AGED; CADAVER; CATALYTIC DOMAIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; SMOKING; TEGMENTUM MESENCEPHALI; TIME FACTORS; UP-REGULATION;

EID: 33847179783     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3661-06.2007     Document Type: Article

References (86)

1. Abou-Saleh MT, Collins J, George A, Rommelspacher H (1994) Adrenoceptor activity and adenylate cyclase inhibition in depression. Br J Psychiatry 165:276-277.
2. Abreu-Villaca Y, Seidler FJ, Slotkin TA (2003) Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal. Brain Res 988:164-172.
3. Beninger RJ, Gerdjikov T (2004) The role of signaling molecules in rewardrelated incentive learning. Neurotox Res 6:91-104.
4. 3H]nicotine binding sites in human brain. J Neurochem 50:1243-1247.
5. Berke JD, Hyman SE (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515-532.
6. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410:376-380.
7. Bozarth MA, Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551-555.
8. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282:7-13.
9. 125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387:385-398.
10. Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351-364.
11. Buisson B, Bertrand D (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23:130-136.
12. Carenzi A, Gillin JC, Guidotti A, Schwartz MA, Trabucchi M, Wyatt RJ (1975) Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients. Arch Gen Psychiatry 32:1056-1059.
13. Carlezon Jr WA, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615.
14. Carlezon Jr WA, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814.
15. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272-2275.
16. Churchill L, Swanson CJ, Urbina M, Kalivas PW (1999) Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 72:2397-2403.
17. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107:285-289.
18. Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM, Lamb H, Perry RH, Johnson M, Perry EK (1998) Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87:63-78.
19. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, O'Neill C (1994) Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 633:297-304.
20. Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P (2001) Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse 42:48-53.
21. De Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31:195-203.
22. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT (1999) G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73:1121-1126.
23. 3H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry 159:66-73.
24. Dwivedi Y, Rizavi HS, Shukla PK, Lyons J, Faludi G, Palkovits M, Sarosi A, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2004) Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 55:234-243.
25. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996) Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
26. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736.
27. Gamberino WC, Gold MS (1999) Neurobiology of tobacco smoking and other addictive disorders. Psychiatr Clin North Am 22:301-312.
28. Gordon HW (2002) Early environmental stress and biological vulnerability to drug abuse. Psychoneuroendocrinology 27:115-126.
29. Hashimoto E, Frolich L, Ozawa H, Saito T, Maurer K, Boning J, Takahata N, Riederer P (1998) Reduced immunoreactivity of type I adenylyl cyclase in the postmortem brains of alcoholics. Alcohol Clin Exp Res 22:88S-92S.
30. Hope BT, Crombag HS, Jedynak JP, Wise RA (2005) Neuroadaptations of total levels of adenylate cyclase, protein kinase A, tyrosine hydroxylase, cdk5 and neurofilaments in the nucleus accumbens and ventral tegmental area do not correlate with expression of sensitized or tolerant locomotor responses to cocaine. J Neurochem 92:536-545.
31. Hsiung SC, Adlersberg M, Arango V, Mann JJ, Tamir H, Liu KP (2003) Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 87:182-194.
32. Izenwasser S, Heller B, Cox BM (1996) Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of ad-enylyl cyclase activity in nucleus accumbens. Eur J Pharmacol 297:187-191.
33. Kalivas PW (2004) Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23-29.
34. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
35. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O'Dell LE, Parsons LH, Sanna PP (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739-749.
36. Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23-47.
37. Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29.
38. Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98:357-362.
39. Lewis DA, Melchitzky DS, Haycock JW (1993) Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience 54:477-492.
40. Lowther S, Crompton MR, Katona CL, Horton RW (1996) GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls. Mol Psychiatry 1:470-477.
41. Lu L, Grimm JW, Shaham Y, Hope BT (2003) Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85:1604-1613.
42. Lynch WJ, Taylor JR (2005) Persistent changes in motivation to self-administer cocaine following modulation of cyclic AMP-dependent protein kinase A (PKA) activity in the nucleus accumbens. Eur J Neurosci 22:1214-1220.
43. Mattson BJ, Bossert JM, Simmons DE, Nozaki N, Nagarkar D, Kreuter JD, Hope BT (2005) Cocaine-induced CREB phosphorylation in nucleus accumbens of cocaine-sensitized rats is enabled by enhanced activation of extracellular signal-related kinase, but not protein kinase A. J Neurochem 95:1481-1494.
44. McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ (2000) The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J Neurochem 74:2120-2126.
45. Memo M, Kleinman JE, Hanbauer I (1983) Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 221:1304-1307.
46. Mousavi M, Hellstrom-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A (2003) Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease. Neuroscience 122:515-520.
47. Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450.
48. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
49. Nestler EJ, Terwilliger RZ, Walker JR, Sevarino KA, Duman RS (1990) Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem 55:1079-1082.
50. Odagaki Y, Garcia-Sevilla JA, Huguelet P, La Harpe R, Koyama T, Guimon J (2001) Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res 898:224-231.
51. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X, Shoemaker W, Duman RS, Nestler EJ (1995) Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21:289-298.
52. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Mondal AC, Shukla PK, Conley RR (2005) Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 30:1548-1556.
53. Parenti M, Gentleman S, Olianas MC, Neff NH (1982) The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivity. Neurochem Res 7:115-124.
54. Parmentier M, Ghysens M, Rypens F, Lawson DE, Pasteels JL, Pochet R (1987) Calbindin in vertebrate classes: immunohistochemical localization and Western blot analysis. Gen Comp Endocrinol 65:399-407.
55. Paxinos G, Mai JK (2004) The human nervous system, Ed 2. Boston: Elsevier Academic.
56. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289:1545-1552.
57. Piazza PV, Deminiere JM, le Moal M, Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22-26.
58. Quattrocki E, Baird A, Yurgelun-Todd D (2000) Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 8:99-110.
59. Reiach JS, Li PP, Warsh JJ, Kish SJ, Young LT (1999) Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J Affect Disord 56:141-151.
60. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
61. Saito T, Ozawa H, Katamura Y, Hatta S, Takahata N, Riederer P (1994) Alterations of receptor-G protein-adenylyl cyclase coupling in alcoholics. Alcohol Alcohol Suppl 2:211-215.
62. Scheggi S, Rauggi R, Nanni G, Tagliamonte A, Gambarana C (2004) Repeated acetyl-L-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum. Eur J Neurosci 19:1609-1620.
63. Schoffelmeer AN, Voorn P, Jonker AJ, Wardeh G, Nestby P, Vanderschuren LJ, De Vries TJ, Mulder AH, Tjon GH (1996) Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization. Neurochem Res 21:1417-1423.
64. Self DW, McClenahan AW, Beitner-Johnson D, Terwilliger RZ, Nestler EJ (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21:312-318.
65. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 18:1848-1859.
66. Shichinohe S, Ozawa H, Saito T, Hashimoto E, Lang C, Riederer P, Takahata N (1998) Differential alteration of adenylyl cyclase subtypes I, II, and V/VI in postmortem human brains of heroin addicts. Alcohol Clin Exp Res 22:84S-87S.
67. Shichinohe S, Ozawa H, Hashimoto E, Tatschner T, Riederer P, Saito T (2001) Changes in the cAMP-related signal transduction mechanism in postmortem human brains of heroin addicts. J Neural Transm 108:335-347.
68. Slotkin TA, Pinkerton KE, Garofolo MC, Auman JT, McCook EC, Seidler FJ (2001) Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated cell signaling in brain and heart of neonatal rats. Brain Res 898:73-81.
69. Sohma H, Hashimoto E, Shirasaka T, Tsunematsu R, Ozawa H, Boissl KW, Boning J, Riederer P, Saito T (1999) Quantitative reduction of type I adenylyl cyclase in human alcoholics. Biochim Biophys Acta 1454:11-18.
70. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41:275-284.
71. Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH (2006) Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci 26:8707-8714.
72. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT (2001) Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 55:625-629.
73. Suto N, Tanabe LM, Austin JD, Creekmore E, Pham CT, Vezina P (2004) Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA. Neuropsychopharmacology 29:2149-2159.
74. Sutton MA, Schmidt EF, Choi KH, Schad CA, Whisler K, Simmons D, Karanian DA, Monteggia LM, Neve RL, Self DW (2003) Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421:70-75.
75. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110.
76. Tolliver BK, Ho LB, Reid MS, Berger SP (1996) Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment. Psychopharmacology (Berl) 126:191-198.
77. Tolliver BK, Ho LB, Fox LM, Berger SP (1999) Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther 289:38-47.
78. Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ (2003) Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry 160:896-903.
79. Tzavara ET, Monory K, Hanoune J, Nomikos GG (2002) Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala. Eur J Neurosci 16:149-153.
80. Valdizan EM, Gutierrez O, Pazos A (2003) Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to betaadrenergic stimulation. Biol Psychiatry 54:1457-1464.
81. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N (2002) Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22:4654-4662.
82. Wise RA (2000) Addiction becomes a brain disease. Neuron 26:27-33.
83. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494.
84. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
85. Yamamoto M, Pohli S, Durany N, Ozawa H, Saito T, Boissl KW, Zochling R, Riederer P, Boning J, Gotz ME (2001a) Increased levels of calcium-sensitive adenylyl cyclase subtypes in the limbic system of alcoholics: evidence for a specific role of cAMP signaling in the human addictive brain. Brain Res 895:233-237.
86. Yamamoto M, Pohli S, Durany N, Ozawa H, Saito T, Boissl KW, Zochling R, Riederer P, Boning J, Gotz ME (2001b) Immunoreactivity of cAMP response element binding protein is not altered in the post-mortem cerebral cortex or cerebellum of alcoholics. Alcohol Alcohol 36:70-74.